• EQUASENS (Ex Pharmagest Interactive): RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 28 JUNE 2022

    Источник: Nasdaq GlobeNewswire / 06 июл 2022 13:01:24   America/New_York

                                                Villers-lès-Nancy, 6 July 2022 - 7:00 p.m. (CET)

    PRESS RELEASE

    RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED
    TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING
    OF 28 JUNE 2022

    Number of shares comprising the share capital: 15,174,125

    Number of shares with voting rights: 15,005,340

    Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,143,135

    The Ordinary Annual General Meeting was held on Tuesday, 28 June 2022 at 5:00 p.m. at the Company’s headquarters and approved the separate parent company and consolidated financial statements for the 2021 financial year. The results of the votes on the resolutions proposed at this meeting by the Board of Directors were as follows:

    Resolutions  

    Results of the votes

     
    • RESOLUTION ONE
    Approval of the annual financial statements    		Resolution adopted by:
    • 13,129,759 votes in favour
    • 0 vote against
    • 13,376 abstentions
    • RESOLUTION TWO
    Discharge of directors and discharge of the Statutory Auditors for the performance of their engagement    		Resolution adopted by:
    • 13,020,494 votes in favour
    • 109,265 votes against
    • 13,376 abstentions
    • RESOLUTION THREE
      Approval of the consolidated financial statements
    		Resolution adopted by:
    • 13,129,759 votes in favour
    • 0 vote against
    • 13,376 abstentions
    • RESOLUTION FOUR
    Appropriation of earnings, setting the dividend    		Resolution adopted by:
    • 13,142,925 votes in favour
    • 210 votes against
    • 0 abstention
    • RESOLUTION FIVE
    Agreements and commitments governed by Articles L. 225-38 of the French Commercial Code    		Resolution adopted by (*):
    • 2,855,465 votes in favour
    • 146,856 votes against
    • 42 abstentions
    • RESOLUTION SIX
    Approval of the information on the compensation of corporate officers paid in or granted for fiscal 2021 and mentioned in Article L. 22-10-9 of the French Commercial Code    		Resolution adopted by:
    • 12,620,491 votes in favour
    • 522,392 votes against
    • 252 abstentions
    • RESOLUTION SEVEN
    Approval of the components of compensation paid in 2021 to Mr. Thierry CHAPUSOT, Chairman of the Board of Directors    		Resolution adopted by:
    • 13,131,917 votes in favour
    • 11,210 votes against
    • 8 abstentions
    • RESOLUTION EIGHT
    Approval of the components of compensation paid in 2021 to Mr. Dominique PAUTRAT, Chief Executive Officer    		Resolution adopted by:
    • 11,304,037 votes in favour
    • 1,838,823 votes against
    • 275 abstentions
    • RESOLUTION NINE
    Approval of the components of compensation paid in 2021 to Mr. Denis SUPPLISSON, Deputy CEO    		Resolution adopted by:
    • 11,138,885 votes in favour
    • 2,003,975 votes against
    • 275 abstentions
    • RESOLUTION TEN
    Approval of the components of compensation paid in 2021 to Mr. Grégoire de ROTALIER, Deputy CEO    		Resolution adopted by:
    • 11,138,885 votes in favour
    • 2,003,975 votes against
    • 275 abstentions
    • RESOLUTION ELEVEN
    Approval of the compensation policy for the Chairman of the Board of Directors for 2022    		Resolution adopted by:
    • 13,131,891 votes in favour
    • 11,210 votes against
    • 34 abstentions
    • RESOLUTION TWELVE
    Approval of the compensation policy for Mr. Dominique PAUTRAT, Chief Executive Officer until 22 April 2022    		Resolution adopted by:
    • 11,213,115 votes in favour
    • 1,929,745 votes against
    • 275 abstentions
    • RESOLUTION THIRTEEN
    Approval of the compensation policy for Mr. Denis SUPPLISSON, Chief Executive Officer as from 23 April 2022    		Resolution adopted by:
    • 11,056,710 votes in favour
    • 2,086,150 votes against
    • 275 abstentions
    • RESOLUTION FOURTEEN
    Approval of the compensation policy for Mr. Denis SUPPLISSON, Deputy Chief Executive Officer until 22 April 2022    		Resolution adopted by:
    • 11,056,710 votes in favour
    • 2,086,150 votes against
    • 275 abstentions
    • RESOLUTION FIFTEEN
    Approval of the compensation policy for Mr. Grégoire de ROTALIER, Deputy Chief Executive Officer for 2022    		Resolution adopted by:
    • 11,056,710 votes in favour
    • 2,086,150 votes against
    • 275 abstentions
    • RESOLUTION SIXTEEN
    Approval of the compensation policy for Directors    		Resolution adopted by:
    • 13,142,891 votes in favour
    • 210 votes against
    • 34 abstentions
    • RESOLUTION SEVENTEEN
    Setting total annual compensation for directors for 2022    		Resolution adopted by:
    • 13,059,925 votes in favour
    • 83,210 votes against
    • 0 abstention
    • RESOLUTION EIGHTEEN
    Authorisation to be given to the Board of Directors to proceed with buybacks of the Company's shares    		Resolution adopted by:
    • 11,477,951 votes in favour
    • 1,665,184 votes against
    • 0 abstention
    • RESOLUTION NINETEEN
    Powers for formalities    		Resolution adopted by:
    • 13,143,127 votes in favour
    • 0 vote against
    • 8 abstentions

    (*) After deduction of excluded voting rights

    Financial Calendar:

    • Publication of H1 2022 Revenue: 3 August 2022.

    About Equasens Group:

    With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

    With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

    Listed on Euronext Paris™ - Compartment A

    Included in the Euronext Tech Leaders segment and the European Rising Tech label
    Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable by inclusion

    Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
    ISIN: FR0012882389 - Ticker Code: EQS

    For all the latest news on Equasens Group go towww.equasens.com

    CONTACTS

    Analyst and Investor Relations:
    Chief Administrative and Financial Officer: Jean-Yves SAMSON
    Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@equasens.com

    Media Relations:
    FIN’EXTENSO - Isabelle APRILE

    +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr  

    Attachment


Опубликовать